Ultromics is unlocking the full potential of echocardiography for advanced heart disease detection and prediction. Discover the power of our groundbreaking AI SaaS platform.
Discover how Automated Echocardiographic Detection of Heart Failure With Preserved Ejection Fraction Using Artificial Intelligence explores the latest research on AI-based Echo Diagnostics
Discover how Association Of A Novel, Non-Invasive AI Model To Automate Echocardiographic Detection Of Heart Failure With Preserved Ejection Failure (HFpEF) With Invasive Hemodynamics explores the latest research on AI-based Echo Diagnostics.
Discover now Automated Echocardiographic Detection of Heart Failure With Preserved Ejection Fraction Using Artificial Intelligence. Explore the latest research on AI-based Echo Diagnostics.
Discover the 2023 HFSA Study Poster -Clinical Utility of An AI-Based Model For Detection of Heart Failure With Preserved Ejection Fraction Using Decision Curve Analysis
Discover the Jacc Advances paper - Automated Detection of HFpEF using AI
Discover how Novel Deep Learning Model For The Detection Of Cardiac Amyloidosis, A Pilot Reader Study explores the latest research on AI-based Echo Diagnostics.
Discover how Automated Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction using Artificial Intelligence explores the latest research on AI-based Echo Diagnostics.
Discover how Comparison Of Clinical Algorithms And AI Applied To An Echocardiogram To Categorize Risk Of HFpEF explores the latest research on AI-based Echo Diagnostics.
In this Cleveland clinic study, EchoGo demonstrated that it can play a role in the risk stratification of hospitalized COVID-19 patients.
This international study aims to determine the clinical and echocardiographic phenotype of acute cardiac disease in COVID-19 patients, using EchoGo Core.
Sign-up to hear about the latest news.
Sign up to newsletter
cases processed